These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 22641480)
21. Demethylzeylasteral (ZST93) inhibits cell growth and enhances cell chemosensitivity to gemcitabine in human pancreatic cancer cells via apoptotic and autophagic pathways. Wang F; Tian X; Zhang Z; Ma Y; Xie X; Liang J; Yang C; Yang Y Int J Cancer; 2018 May; 142(9):1938-1951. PubMed ID: 29238973 [TBL] [Abstract][Full Text] [Related]
22. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters. Qiu F; Chen J; Cao J; Diao F; Huang P Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228 [TBL] [Abstract][Full Text] [Related]
23. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100 [TBL] [Abstract][Full Text] [Related]
24. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling. Qian Y; Yang B; Xiong Y; Gu M Oncol Rep; 2016 Sep; 36(3):1517-25. PubMed ID: 27459907 [TBL] [Abstract][Full Text] [Related]
25. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib. Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870 [TBL] [Abstract][Full Text] [Related]
26. Pachymic acid inhibits growth and induces apoptosis of pancreatic cancer in vitro and in vivo by targeting ER stress. Cheng S; Swanson K; Eliaz I; McClintick JN; Sandusky GE; Sliva D PLoS One; 2015; 10(4):e0122270. PubMed ID: 25915041 [TBL] [Abstract][Full Text] [Related]
27. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. Park B; Prasad S; Yadav V; Sung B; Aggarwal BB PLoS One; 2011; 6(10):e26943. PubMed ID: 22066019 [TBL] [Abstract][Full Text] [Related]
28. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406 [TBL] [Abstract][Full Text] [Related]
29. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Arlt A; Gehrz A; Müerköster S; Vorndamm J; Kruse ML; Fölsch UR; Schäfer H Oncogene; 2003 May; 22(21):3243-51. PubMed ID: 12761494 [TBL] [Abstract][Full Text] [Related]
30. BMS-754807, a small-molecule inhibitor of insulin-like growth factor-1 receptor/insulin receptor, enhances gemcitabine response in pancreatic cancer. Awasthi N; Zhang C; Ruan W; Schwarz MA; Schwarz RE Mol Cancer Ther; 2012 Dec; 11(12):2644-53. PubMed ID: 23047891 [TBL] [Abstract][Full Text] [Related]
31. CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosis. Subramaniam D; Periyasamy G; Ponnurangam S; Chakrabarti D; Sugumar A; Padigaru M; Weir SJ; Balakrishnan A; Sharma S; Anant S Mol Cancer Ther; 2012 Jul; 11(7):1598-608. PubMed ID: 22532602 [TBL] [Abstract][Full Text] [Related]
32. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts. Waters JA; Matos J; Yip-Schneider M; Aguilar-Saavedra JR; Crean CD; Beane JD; Dumas RP; Suvannasankha A; Schmidt CM Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568 [TBL] [Abstract][Full Text] [Related]
33. Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Wang SJ; Gao Y; Chen H; Kong R; Jiang HC; Pan SH; Xue DB; Bai XW; Sun B Cancer Lett; 2010 Jul; 293(1):99-108. PubMed ID: 20137856 [TBL] [Abstract][Full Text] [Related]
34. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells. Lin JH; Chen SY; Lu CC; Lin JA; Yen GC Phytother Res; 2020 Aug; 34(8):2053-2066. PubMed ID: 32185829 [TBL] [Abstract][Full Text] [Related]
35. Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway. Gao N; Cheng S; Budhraja A; Gao Z; Chen J; Liu EH; Huang C; Chen D; Yang Z; Liu Q; Li P; Shi X; Zhang Z Br J Pharmacol; 2012 Mar; 165(6):1813-1826. PubMed ID: 21950524 [TBL] [Abstract][Full Text] [Related]
36. The Apoptotic Effect of Ursolic Acid on SK-Hep-1 Cells is Regulated by the PI3K/Akt, p38 and JNK MAPK Signaling Pathways. Chuang WL; Lin PY; Lin HC; Chen YL Molecules; 2016 Apr; 21(4):460. PubMed ID: 27104510 [TBL] [Abstract][Full Text] [Related]
37. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation. Zhuang Z; Li H; Lee H; Aguilar M; Gocho T; Ju H; Iida T; Ling J; Fu J; Wu M; Sun Y; Lu Y; Chiao PJ Cancer Lett; 2017 Dec; 411():44-56. PubMed ID: 28951128 [TBL] [Abstract][Full Text] [Related]
38. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway. Liu J; Huang Y; Liu Y; Chen Y Med Sci Monit; 2019 Aug; 25():6085-6096. PubMed ID: 31412018 [TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer. Tian X; Hao K; Qin C; Xie K; Xie X; Yang Y Dig Dis Sci; 2013 Sep; 58(9):2705-12. PubMed ID: 23589145 [TBL] [Abstract][Full Text] [Related]
40. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Ahn DW; Seo JK; Lee SH; Hwang JH; Lee JK; Ryu JK; Kim YT; Yoon YB Pancreas; 2012 Oct; 41(7):1048-57. PubMed ID: 22513291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]